CPAP versus Oxygen in Obstructive Sleep Apnea Daniel J. Gottlieb, M.D., M.P.H., Naresh M. Punjabi, M.D., Ph.D., Reena Mehra, M.D., Sanjay R. Patel, M.D.,

Slides:



Advertisements
Similar presentations
Medical Complications
Advertisements

PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Trademarks may be registered and are the property of their respective owners. Today’s discussion may regard information or indications not evaluated by.
Does the Modified Mallampati Scoring Method Effectively Screen for Obstructive Sleep Apnea (OSA)? Isadore Tarantino 1, Tim Quinn 1, Larry Dall 1, Nurry.
Sleep Apnea and Cardiovascular Disease
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
TROPHY TRial Of Preventing HYpertension. High-normal BP increases CV risk Vasan RS et al. N Engl J Med. 2001;345: Incidence of CV events in women.
Martin Duke, MD, MRO February 20, Agenda What is OSA? Obstructive Sleep Apnea Cycle Steps in OSA Evaluation.
Early Identification of Obstructive Sleep Apnea and Prevention of Long Term Health Risks Becky Ellis, RN, BSN.
By Cyneetha Strong, MD May 19,  Diseases and conditions pertaining to the heart and vascular (blood vessels) system  Primarily includes heart.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring.
Heart Disease Effects of lifestyle on coronary heart disease Sara Quale ∙ Concordia University-Nebraska 1.
Obstructive Sleep Apnea: Is it in your Differential? Helene Hill Professor Sam Powdrill PAS 645.
September 11, 2012 Mike Hummel Watermark Medical Obstructive Sleep Apnea (OSA) Impacting Workplace Safety and Cost.
Obstructive sleep apnea  Obstructive sleep apnea (OSA) is a common sleep apnea caused by obstruction of the airway.  It is characterized by pauses in.
Women's Health Study: Low-Dose Aspirin in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Dr.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Sleep Apnea in the Cardiac Patient Stephen Jennison.
Katy L. Gordon, BSN, RN What are the Statistics? Centers for Disease Control (2009). Adult obesity: Obesity rises among adults.
Stroke Awareness & Prevention Suheb Hasan, MD Health Seminar MCWS November 17, 2012.
Obstructive Sleep Apnea of Obese Adults Obstructive Sleep Apnea of Obese Adults Pathophysiology and Perioperative Airway Management Anesthesiology, 2009,
DECREASING SLEEP-TIME BLOOD PRESSURE DETERMINED BY AMBULATORY MONITORING REDUCES CARDIOVASCULAR RISK Ramón C. Hermida, PhD; Diana E. Ayala, MD, MPH, PhD;
Obesity means having too much body fat. It is different from being overweight, which means weighing too much. Both terms mean that a person's weight is.
OSA Pathogenesis, Co-morbidities and Outcomes John Reid, MD FRCP(C) RMGIM Conference, Banff November 24, 2012.
OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE By Ahmad Younis Professor.
Renji Hospital Pro Wang Sleep related hypoventilation/hypoxemia.
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
Copyleft Clinical Trial Results. You Must Redistribute Slides HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)
Student Curtui Madalina Cristina, MG, an VI University of Medicine and Pharmacy Targu Mures Coordinator: Dr.Neagos Adriana, MD.PhD.
Evaluating a Case of Sleep Apnoea Dr J.M. Joshi Professor and Head Department of Pulmonary Medicine T.N. Medical College B.Y.L. Nair Hospital Mumbai.
Sleep Apnea Hope Haddad March 16, What is Sleep Apnea? Sleep apnea is a common disorder in which you have one or more pauses in breathing or shallow.
The Importance of Sleep
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Continuous Positive Airway Pressure for Heart Patients with Central Sleep Apnea Presented at American College of Cardiology Scientific Sessions 2005 Presented.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Signs we are ALIVE Vital Signs.
A Controlled Trial of Renal Denervation for Resistant Hypertension
Ethnicity and Cardiovascular Disease Africans Americans.
2007 Hypertension as a Public Health Risk January, 2007.
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
THE SECRET LIFE OF SNORERS PRESENTED BY ^ Sex Content By: Snoring Isn’t Sexy, LLC.
A Randomized Trial of Intensive versus Standard Blood-Pressure Control The SPRINT Research Group* November 9, /NEJMoa R2 이성곤 /pf. 우종신.
Relationship Between Sleep and Obesity. Why We Need Sleep! A good night sleep is very important to a person’s overall health and their ability to function.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
호흡기내과 금요저널컨퍼런스 R3 박재훈 / Prof. 임효석.  Obesity & obstructive sleep apnea(OSA) ◦ linked to insulin resistance, dyslipidemia, HTN, inflammation ◦
T HREE STRIKES IS ENOUGH Karalyn J Huxhagen B Pharm FPS AACPA Cardiovascular Health Sleep Apnoea Diabetes.
Date of download: 7/15/2016 From: Diagnosis and Initial Management of Obstructive Sleep Apnea without Polysomnography: A Randomized Validation Study Ann.
Graph paper template R2 이지훈 / Prof. 박명재 N Engl J Med 2014;370:
Antonio Coca, MD, PhD, FRCP, FESC
Management of Hypertension according to JNC 7
Prof. Dr. ABDUL HAMEED AL QASEER
Atrial Fibrillation and Obstructive Sleep Apnea
Hypertension November 2016
Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)
From ESH 2016 | POS 3C: Chiara Lorenzi, MD
CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.
What’s New in the 2013 ESC/ESH Hypertension Guideline
Copyright © 2007 American Medical Association. All rights reserved.
Treatment Thresholds and Non-Pharmacologic Therapy
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
SAVE Trial design: Patients with moderate to severe obstructive sleep apnea (OSA) and known CV disease were randomized in a 1:1 fashion to either CPAP.
The Hypertension in the Very Elderly Trial (HYVET)
What It Is and Why It Matters
Primary Hypertension Max C. Reif, M.D.
Hypertension November 2016
Clinician Referral Training
OVERVIEW OF SLEEP DISORDERED BREATHING (SDB)
Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,
Presentation transcript:

CPAP versus Oxygen in Obstructive Sleep Apnea Daniel J. Gottlieb, M.D., M.P.H., Naresh M. Punjabi, M.D., Ph.D., Reena Mehra, M.D., Sanjay R. Patel, M.D., Stuart F. Quan, M.D., Denise C. Babineau, Ph.D., Russell P. Tracy, Ph.D., Michael Rueschman, M.P.H., Roger S. Blumenthal, M.D., Eldrin F. Lewis, M.D., Deepak L. Bhatt, M.D., M.P.H., and Susan Redline, M.D., M.P.H. R1 전민아 N Engl J Med 2014;370:

Introduction  CPAP(continuous positive airway pressure)  Forces air into the nasal passages at pressures high enough to overcome obstructions in the airway and stimulate normal breathing  Airway pressure delivered into the upper airway is continuous during both inspiration and expiration.  Treatment for moderate to severe obstructive sleep apnea

Introduction  Obstructive sleep apnea  Highly prevalent, chronic illness in adults  Risk factor for hypertension, coronary heart disease, stroke, and death  Screening  Berlin questionnaire : Snoring and cessation of breathing Daytime sleepiness Obesity and HTN  Epworth Sleepiness Scale : Self-reported measure of daytime sleepiness

Method  Four-site, randomized, parallel-group clinical trial  Patients were managed by cardiologists  Education on habits promoting sleep hygiene and a healthy lifestyle was provided to all participant  AHI 15~50/hr were randomly assigned  24-hour mean arterial pressure were measured at baseline and after 12 weeks of treatment

Results

no significant difference Forrest IA : active arterial bleeding Forrest IB : oozing bleeding Forrest IIA : Visible vessel Forrest IIB : Adherent clot

Results

 Secondary analysis  Age, sex, race, baseline body-mass index, AHI, and use or nonuse of each class of antihypertensive medication → no appreciable influence  reactive hyperemia index → no significant difference

 In patients with cardiovascular disease or multiple cardiovascular risk factors, the treatment of obstructive sleep apnea with CPAP, but not nocturnal supplemental oxygen, resulted in a significant reduction in blood pressure  The average decrease in blood pressure resulting from CPAP was modest as compared with the effect of antihypertensive medications  sBP 2mmHg↓  ↓ Mortality from stroke by 10%  ↓ mortality from ischemic heart disease or other vascular causes by 7% Discussion

 The effect of CPAP appears to be greatest at night  However, treating physician should consider using supplemental oxygen in specific patients Discussion

Thank you for your attention